We are live on
!
Find out more
BL
Bleichroeder LP Portfolio holdings
AUM
$559M
Turnover
17.24%
1-Year Est. Return
83.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.64%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$493M
AUM Growth
+$24M
(+5.1%)
Cap. Flow
+$24.3M
Cap. Flow
% of AUM
4.93%
Top 10 Holdings %
Top 10 Hldgs %
73.64%
Holding
90
New
10
Increased
4
Reduced
3
Closed
7
Avg Time Held
2.2
years
Top 10 Avg Time Held
1.8
years
Top 20 Avg Time Held
2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paragon 28, Inc.
FNA
|
+$31.7M |
| 2 |
Insmed
INSM
|
+$5.68M |
| 3 |
Ashland
ASH
|
+$3.75M |
| 4 |
Dragonfly Energy
DFLI
|
+$2.48M |
| 5 |
DuPont de Nemours
DD
|
+$2.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$16.4M |
| 2 |
Thor Industries
THO
|
+$12.4M |
| 3 |
BRIV
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
|
+$2.29M |
| 4 |
Finch Therapeutics Group, Inc. Common Stock
FNCH
|
+$267K |
| 5 |
iSpecimen
ISPC
|
+$88.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.15% |
| 2 | Consumer Discretionary | 18.86% |
| 3 | Miscellaneous | 17.38% |
| 4 | Industrials | 13.81% |
| 5 | Materials | 10.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Curis
CRIS
$1.39M
| $208K | 0.04% |
625
| – | – |
2020 Q4
10 quarters
|
|
52
Sprott Physical Gold
PHYS
$14.9B
| $187K | 0.04% |
12,540
| – | – |
2019 Q4
14 quarters
|
|
53
Liberty Latin America Class C
LILAK
$1.61B
| $142K | 0.03% |
18,174
| – | – |
2020 Q2
12 quarters
|
|
|
LGF.B
54
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $137K | 0.03% |
16,413
| – | – |
2019 Q4
14 quarters
|
|
55
Cadence Design Systems
CDNS
$88.7B
| $123K | 0.03% |
525
| – | – |
2020 Q2
12 quarters
|
|
56
ExxonMobil
XOM
$719B
| $115K | 0.02% |
1,075
| – | – |
2020 Q2
12 quarters
|
|
57
DELISTED
CompoSecure Inc Warrant
CMPOW
| $105K | 0.02% |
100,000
| – | – |
2022 Q1
5 quarters
|
|
58
Advanced Micro Devices
AMD
$894B
| $104K | 0.02% |
913
| – | – |
2022 Q1
5 quarters
|
|
59
Bank of New York Mellon
BNY
$96.3B
| $89K | 0.02% |
2,000
| – | – |
2020 Q1
13 quarters
|
|
60
AbbVie
ABBV
$510B
| $69.4K | 0.01% |
515
| – | – |
2020 Q2
12 quarters
|
|
61
Teradyne
TER
$52.6B
| $66.8K | 0.01% |
600
| – | – |
2020 Q2
12 quarters
|
|
62
Altria Group
MO
$123B
| $54.4K | 0.01% |
1,200
| – | – |
2020 Q2
12 quarters
|
|
|
INFI
63
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $52.6K | 0.01% |
250,000
| – | – |
2019 Q4
14 quarters
|
|
64
Lumentum
LITE
$76.7B
| $37.4K | 0.01% |
660
| – | – |
2020 Q2
12 quarters
|
|
65
Liberty Latin America Class A
LILA
$1.62B
| $35.1K | 0.01% |
5,913
| – | – |
2020 Q1
13 quarters
|
|
66
X4 Pharmaceuticals
XFOR
$256M
| $34.7K | 0.01% |
596
-595
| -50% | -$30.6K |
2019 Q4
14 quarters
|
|
|
EQRXW
67
DELISTED
EQRx, Inc. Warrant
EQRXW
| $33.7K | 0.01% |
200,000
| – | – |
2021 Q2
8 quarters
|
|
68
ARK Genomic Revolution ETF
ARKG
$2.07B
| $28.1K | 0.01% |
825
| – | – |
2022 Q1
5 quarters
|
|
69
SaverOne 2014 Ltd Warrant
SVREW
| $26.7K | 0.01% |
121,000
| – | – |
2022 Q2
4 quarters
|
|
70
AT&T
T
$162B
| $26.3K | 0.01% |
1,650
| – | – |
2020 Q2
12 quarters
|
|
71
ARK Blockchain & Fintech Innovation ETF
ARKF
$896M
| $25.1K | 0.01% |
1,200
| – | – |
2022 Q1
5 quarters
|
|
72
ARK Next Generation Technology ETF
ARKW
$2.21B
| $17.6K | ﹤0.01% |
300
| – | – |
2022 Q1
5 quarters
|
|
73
DELISTED
OppFi Inc Warrants
OPFI.WS
| $17.5K | ﹤0.01% |
250,000
| – | – |
2021 Q3
7 quarters
|
|
|
CORS.WS
74
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
| $11.3K | ﹤0.01% |
416,666
| – | – |
2021 Q3
7 quarters
|
|
75
Alliance Entertainment Holding Corp Warrants
AENTW
| $9.4K | ﹤0.01% |
+200,000
| New | +$9.4K |
2023 Q2
0 quarters
|
|
Similar funds
NFW
SCM
PHC
EPM
BCM
FAM
WDG
OC
Bleichroeder LP's Q2 2023 Portfolio in Review
As of Q2 2023, Bleichroeder LP held 90 positions worth $493M, up 5.1% from $469M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Bleichroeder LP deployed $24.3M of net new capital in Q2 2023, opening 10 new positions and adding to 4 existing holdings. Its largest new stake was Paragon 28, Inc.: 1,763,339 shares worth $26.8M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Miscellaneous.
On the sell side, the largest reduction was Thor Industries, an estimated $12.4M trimmed.
- Bleichroeder LP's largest Q2 2023 buy was Paragon 28, Inc.: 1,763,339 shares worth $26.8M.
- Bleichroeder LP added most to Insmed in Q2 2023, an estimated $5.68M increase.
- Bleichroeder LP's biggest Q2 2023 reduction was Thor Industries, cutting an estimated $12.4M.
- Bleichroeder LP fully exited CTI BioPharma Corp. (DE) Common Stock in Q2 2023, selling an estimated $16.4M.
- Bleichroeder LP's ten largest holdings make up 74% of its $493M portfolio in Q2 2023.
- Bleichroeder LP opened 10 new positions and closed 7 in Q2 2023.
- Bleichroeder LP's portfolio value rose 5.1% quarter-over-quarter to $493M.
Based on Bleichroeder LP's 13F filing for Q2 2023, filed 14 Aug 2023.